IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.296
0.00 (-0.13%)
At close: Jan 17, 2025, 4:00 PM
0.290
-0.006 (-2.03%)
After-hours: Jan 17, 2025, 7:52 PM EST
IN8bio Market Cap
IN8bio has a market cap or net worth of $21.47 million as of January 17, 2025. Its market cap has decreased by -59.96% in one year.
Market Cap
21.47M
Enterprise Value
22.94M
1-Year Change
-59.96%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $21.47M, a decrease of -88.55%. That is a compound annual growth rate of -46.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 21.47M | 15.16% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |